Skip to main content
Clinical Trials/NCT04294732
NCT04294732
Completed
Phase 4

Efficacy of Popliteal Block and Bupivacaine Concentration Used for Analgesia in Foot and Ankle Surgery

Bozyaka Training and Research Hospital1 site in 1 country68 target enrollmentApril 1, 2018

Overview

Phase
Phase 4
Intervention
Only spinal anesthesia without peripheral nerve block
Conditions
Foot and Ankle Surgery
Sponsor
Bozyaka Training and Research Hospital
Enrollment
68
Locations
1
Primary Endpoint
pain relief activity of popliteal nerve block within thirty-six hours
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

In the orthopedic foot and ankle surgeries, the effects of postoperative popliteal nerve block applied for palliation of pain and local anesthetic agent in two different concentrations (0.166 and 0.250) which were used in popliteal nerve block procedure, will be investigated.

Detailed Description

USG guided popliteal nerve block known to be effective in postoperative pain management in foot and ankle surgical procedures but clinical use of the procedure is not yet widespread. However, the volume and concentration of local anesthetic drugs to be administered is still controversial. The study was designed to be prospective and randomized. Patients will be divided into 3 groups by simple randomization. The results of power analysis (G-power 3.1) revealed that a total of 60 patients were required to be included in the study. Because of that, approximately 20 patients are planned for each group. Spinal anesthesia will be performed in all three groups. During procedure 8 ml saline with 8 ml bupivacaine will be apply to the first group and 8 ml bupivacaine and 16 ml of saline will be apply to the second group. Only spinal anesthesia will be given to the third group without peripheral nerve block. The patients participating in the study will not be informed about which group they belong to, the person who makes the block will not prepare the drug and the person who makes the block, the patient and the nurse will not know which concentration drug applied to which patient. Between two groups duration of motor block, duration of sensory block, post-op analgesia time, mobilization time will be investigate. Also the first pain time, the opioid requirement and opioid dose used will be investigated. Analgesia, duration of analgesia, time and requirement of administered IV analgesics, mobilization time after popliteal nerve block will be investigate. package statistical program SPSS (Statistical Package for Social Sciences version 18) will be used for statistical analysis. The parametrical values from the descriptive values will be given as mean and standard deviation, the non-parametric values will be given as number and percentage or median and min-max value. The suitability of the data to the normal distribution will be evaluated with the Kolmogorov-Smirnov test. One-way ANOVA will be use for the comparison of the quantitative data which is appropriate to the normal distribution. The Tukey HSD test will be used to identify the group that caused the difference. Kruskal Wallis-H test will be used to compare quantitative parameters that do not show normal distribution. Mann Whitney U test will be applied to determine the cause of the difference and chi-square test will be used to compare qualitative data. For the analyzes, the level of significance in the 95% confidence interval was found in p \< 0.05.

Registry
clinicaltrials.gov
Start Date
April 1, 2018
End Date
January 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bozyaka Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Hazal Ezgi Çifci

Principal Investigator Hazal Ezgi Çifci

Bozyaka Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patients undergoing orthopedic surgery on foot and ankle and who agreed to participate in the study

Exclusion Criteria

  • Patients with sensitivity to local anesthetic
  • Patients who do not want to be included in the study
  • Preoperative mobilization and movement limitation
  • Patients who are not co-operate, cannot complete questionnaire forms and inquiry forms
  • Patients with skin infection at the injection site
  • Patients with diabetic neuropathy
  • Patients with bleeding disorder / Coagulopathy
  • Pregnancy

Arms & Interventions

Only spinal anesthesia

Only spinal anesthesia without peripheral nerve block

Intervention: Only spinal anesthesia without peripheral nerve block

high concentration

8 ml saline with 8 ml bupivacaine

Intervention: Bupivacaine

low concentration

8 ml bupivacaine with 16 ml of saline

Intervention: Bupivacaine

Outcomes

Primary Outcomes

pain relief activity of popliteal nerve block within thirty-six hours

Time Frame: Postoperative 36th hour

Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 36th hour. İf the numeric rating scale is above 3, it will be considered as pain.

pain relief activity of popliteal nerve block within three months

Time Frame: Postoperative third month

Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at third months. İf the numeric rating scale is above 3, it will be considered as pain. İf pain persist over 1 month, ıt will be considered as chronic pain.

Secondary Outcomes

  • Investigate the pain relief activity of different concentrations within thirty-six hours(Postoperative 36th hour)
  • Investigate the pain relief activity of different concentrations within three months(Postoperative third month)

Study Sites (1)

Loading locations...

Similar Trials